AMANDA LEWIS
Allopathic & Osteopathic Physicians|Allergy & Immunology|Allergy LUBBOCK, TX NPI 1972949048
Browse related groups: Allopathic & Osteopathic Physicians|Allergy & Immunology|Allergy TX Acerta Pharma LLC All categories
General Payments — all program years on this page
$4,341.00
- Category: General Payments
- Program years: PY2018–2024
- Record count: 216
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,163.73 across 54 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,163.73 | 54 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $356.31 | 10 |
| Grifols USA, LLC | $162.13 | 16 |
| Regeneron Healthcare Solutions, Inc. | $119.99 | 2 |
| Pharming Healthcare, Inc. | $100.70 | 5 |
| Mylan Specialty L.P. | $66.95 | 3 |
| CSL Behring | $62.44 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.65 | 3 |
| Genentech USA, Inc. | $51.94 | 3 |
| ABBVIE INC. | $33.12 | 2 |
| Blueprint Medicines Corporation | $30.13 | 1 |
| GENZYME CORPORATION | $25.10 | 1 |
| REVANCE THERAPEUTICS, INC. | $22.50 | 1 |
| BioCryst US Sales Co., LLC | $20.37 | 1 |
| PFIZER INC. | $19.37 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.85 | 1 |
| GlaxoSmithKline, LLC. | $18.18 | 1 |
By program year
Records — PY2024 (54)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.